Magungunan Antidepressants na iya Rage Haɗarin Mutuwa A cikin COVID-19 Marasa lafiya: Nazari
Magungunan Antidepressants na iya Rage Haɗarin Mutuwa A cikin COVID-19 Marasa lafiya: Nazari
Anonim

Fluoxetine na yau da kullun na antidepressant, wanda ake siyarwa a ƙarƙashin alamar sunan Prozac, kwanan nan an gano yana rage haɗarin mutuwa na marasa lafiya da ke fama da cutar COVID-19 mai tsanani.

Nazarin

Wani babban binciken da ke amfani da bayanai daga marasa lafiya 83, 584 da aka gano tare da COVID-19 daga cibiyoyin kiwon lafiya 87 a cikin Amurka sun gano cewa gudanar da zaɓin masu hana sake dawo da serotonin yana da tasiri kan mace-macen marasa lafiya da ke da COVID-19 mai tsanani.

Binciken, wanda aka buga a jaridar JAMA Network Open jiya litinin, ya nuna cewa majinyata 3,401 da aka bai wa magungunan kashe-kashe sun rage yawan mace-mace idan aka kwatanta da rukunin marasa lafiya 6,802 da ba su karbi maganin ba.

Daga cikin marasa lafiya 3,401 da aka wajabta tare da SSRIs, 470 sun karɓi fluoxetine kawai kuma kusan 9.8% ko 46 daga cikinsu sun mutu. Wannan yana da ƙasa kaɗan idan aka kwatanta da sama da 13% ko fiye da marasa lafiya 930 waɗanda suka mutu daga cikin mahalarta 7,050 a cikin rukunin kulawa da ba a kula da su ba.

An kuma yi amfani da sauran magungunan kashe kwayoyin cuta a cikin binciken, ciki har da fluvoxamine, kuma sun ba da kashi mafi girma idan aka kwatanta da na fluoxetine amma ƙasa da ƙimar daga ƙungiyar kulawa da ba a kula da su ba.

An kuma gano Fluvoxamine don rage haɗarin majinyacin SARS-CoV-2 ya ƙare a asibiti, dangane da gwajin da aka yi kwanan nan a Brazil. Masu bincike ne suka bincikar shi saboda ana la'akari da shi azaman madadin mai rahusa ga Merck & Co.'s antiviral don COVID-19, a cewar Bloomberg.

Takeaway

An yi amfani da magungunan kashe-kashe kamar fluoxetine da fluvoxamine don kula da yanayin lafiyar hankali kusan shekaru 30 yanzu. Ƙarfinsu na haɓaka matakan serotonin a cikin kwakwalwa shine abin da ke sa su tasiri wajen magance matsalolin tunani.

Abin sha'awa, waɗannan magungunan kuma na iya yin aiki azaman masu hana kumburi waɗanda zasu iya taimakawa sauƙaƙe alamun a cikin marasa lafiya na COVID-19. Dokta Yogesh Shah a Cibiyar Kiwon Lafiya ta Broadlawns ya gaya wa KCCI News cewa sakamakon sabon binciken yana da "alƙawari sosai."

Shash ya ce alama ce mai kyau cewa ana iya amfani da wasu magungunan kashe-kashe da aka yi amfani da su a cikin binciken wajen kula da masu cutar SARS-CoV-2. Koyaya, ana buƙatar ƙarin bincike don tabbatar da binciken.

"Yana da alama mai albarka. Kamar yadda na ambata, ba zan fita in ba da takardar sayan magani ga marasa lafiya ba, amma yana da kyau, "in ji shi kafin ya lura cewa bai kamata a kalli magungunan rage damuwa a matsayin maye gurbin maganin rigakafi ba.

Amma ga marubucin binciken Tomiko Oskotsky, MD, na Jami'ar California, San Francisco, sakamakon yana da "ƙarfafawa" musamman ga masana kimiyya da ƙwararrun likitocin da ke neman wasu hanyoyin magance cutar.

"Yana da mahimmanci a sami yawancin zaɓuɓɓuka kamar yadda zai yiwu don magance kowane irin yanayi. Wani magani ko magani ba zai yi aiki ba ko kuma kowa ya yarda da shi sosai. Bayanai daga bayanan likitancin lantarki suna ba mu damar bincikar magungunan da ke akwai waɗanda za a iya sake yin su don magance COVID-19 ko wasu yanayi,”MedPage Today ya nakalto Oskotsky yana cewa.

Shahararren taken